Cite
Impact of clozapine once-daily versus multiple-daily dosing regimen on relapse in patients with treatment-resistant schizophrenia: A 1-year retrospective cohort study.
MLA
Tsukahara, Masaru, et al. “Impact of Clozapine Once-Daily versus Multiple-Daily Dosing Regimen on Relapse in Patients with Treatment-Resistant Schizophrenia: A 1-Year Retrospective Cohort Study.” Psychopharmacology, Aug. 2024. EBSCOhost, https://doi.org/10.1007/s00213-024-06658-x.
APA
Tsukahara, M., So, R., Kitagawa, K., Yada, Y., Kodama, M., Nakajima, S., Kishi, Y., Yamada, N., & Takeuchi, H. (2024). Impact of clozapine once-daily versus multiple-daily dosing regimen on relapse in patients with treatment-resistant schizophrenia: A 1-year retrospective cohort study. Psychopharmacology. https://doi.org/10.1007/s00213-024-06658-x
Chicago
Tsukahara, Masaru, Ryuhei So, Kohei Kitagawa, Yuji Yada, Masafumi Kodama, Shinichiro Nakajima, Yoshiki Kishi, Norihito Yamada, and Hiroyoshi Takeuchi. 2024. “Impact of Clozapine Once-Daily versus Multiple-Daily Dosing Regimen on Relapse in Patients with Treatment-Resistant Schizophrenia: A 1-Year Retrospective Cohort Study.” Psychopharmacology, August. doi:10.1007/s00213-024-06658-x.